ARTICLE | Company News
Immunotope, Midatech deal
July 19, 2010 7:00 AM UTC
The companies formed a 50/50 JV, Syntara LLC, to develop antigen-based immune therapies to treat chronic viral infections and cancer. Midatech will license Syntara IP related to nanomedicine, and Immu...